Skip to Main Content

Paper Details

IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma.
Cancer Lett
49
2020
EGFR, IGFBP2, PD-1, PD-L1, STAT3, immune, malignant melanoma, melanoma, melanoma cells, patients
Author NameAffiliation
Da YangDepartment of Pharmaceutical Sciences, University of Pittsburgh
Wei ZhangCenter for Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest School of Medicine
Jilong YangTianjin Medical University Cancer Institute and Hospital, People's Republic of China National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer
  • 1 - 3

Datasets